Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 02 2023
Historique:
received: 02 12 2022
revised: 07 02 2023
accepted: 14 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

The estrogen receptor α (ERα) corresponds to a large platform in charge of the recruitment of a panel of molecules, including steroids and related heterocyclic derivatives, oligonucleotides, peptides and proteins. Its 295-311 region is particularly targeted by post-translational modifications, suggesting that it could be crucial for the control of transcription. In addition to anionic phospholipids, the ERα 295-311 fragment interacts with Ca

Identifiants

pubmed: 36831322
pii: cells12040653
doi: 10.3390/cells12040653
pmc: PMC9954065
pii:
doi:

Substances chimiques

Estrogen Receptor alpha 0
Estrogens 0
Receptors, G-Protein-Coupled 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Biochem Biophys Res Commun. 2012 Mar 9;419(2):356-61
pubmed: 22342729
Methods Mol Biol. 2016;1366:241-259
pubmed: 26585140
Chem Sci. 2019 Oct 3;10(45):10595-10600
pubmed: 32110345
Bioorg Med Chem Lett. 2018 Feb 15;28(4):658-663
pubmed: 29395974
Cells. 2019 Mar 07;8(3):
pubmed: 30866584
Essays Biochem. 2021 Dec 17;65(6):867-875
pubmed: 34028522
Anticancer Agents Med Chem. 2019;19(6):760-771
pubmed: 30451119
Biochem J. 2015 Nov 15;472(1):97-109
pubmed: 26371374
Front Endocrinol (Lausanne). 2020 Nov 23;11:591217
pubmed: 33329395
Biochemistry. 2016 Sep 27;55(38):5366-76
pubmed: 27641460
Sci Rep. 2023 Jan 24;13(1):1326
pubmed: 36693877
Mol Oncol. 2013 Jun;7(3):595-610
pubmed: 23474223
Steroids. 2012 Aug;77(10):979-87
pubmed: 22426414
Mol Endocrinol. 2000 Oct;14(10):1649-60
pubmed: 11043579
Nucl Recept Signal. 2008 Apr 18;6:e007
pubmed: 18432312
EMBO J. 1992 Oct;11(10):3681-94
pubmed: 1327748
J Steroid Biochem Mol Biol. 2018 Feb;176:49-56
pubmed: 28249728
Essays Biochem. 2021 Dec 17;65(6):857-866
pubmed: 34061186
Chirality. 2013 Oct;25(10):628-42
pubmed: 23925889
J Exp Clin Cancer Res. 2019 Aug 1;38(1):335
pubmed: 31370872
Front Endocrinol (Lausanne). 2022 Jun 30;13:943343
pubmed: 35846328
Endocrinology. 2003 Jun;144(6):2425-36
pubmed: 12746304
Int J Mol Sci. 2019 Jan 14;20(2):
pubmed: 30646517
Biochemistry. 1995 Oct 3;34(39):12605-15
pubmed: 7548010
J Steroid Biochem Mol Biol. 2019 May;189:176-186
pubmed: 30851383
Int J Mol Sci. 2018 Jun 27;19(7):
pubmed: 29954076
Front Endocrinol (Lausanne). 2020 Mar 31;11:148
pubmed: 32296387
Front Endocrinol (Lausanne). 2022 Sep 06;13:954629
pubmed: 36147566
Clin Cancer Res. 2006 Nov 1;12(21):6359-66
pubmed: 17085646
Cells. 2019 Jun 14;8(6):
pubmed: 31207943
Future Med Chem. 2015;7(4):437-48
pubmed: 25875871
Molecules. 2018 Apr 12;23(4):
pubmed: 29649162
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Cancers (Basel). 2022 May 21;14(10):
pubmed: 35626139
Ann Pharm Fr. 2019 Nov;77(6):488-495
pubmed: 31563266
Cells. 2020 Mar 04;9(3):
pubmed: 32143514
Anticancer Agents Med Chem. 2018;18(11):1629-1638
pubmed: 29745344
Mol Endocrinol. 2005 Nov;19(11):2671-84
pubmed: 15961505
J Pept Sci. 2015 Feb;21(2):95-104
pubmed: 25530026
EMBO J. 2009 Mar 4;28(5):523-32
pubmed: 19153601
Front Endocrinol (Lausanne). 2020 Aug 04;11:517
pubmed: 32849301
J Steroid Biochem Mol Biol. 2007 Apr;104(1-2):1-10
pubmed: 17258904
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):138-49
pubmed: 18262408
Oncogene. 2010 Apr 22;29(16):2404-14
pubmed: 20101208
Methods Mol Biol. 2022;2418:345-362
pubmed: 35119674
Mol Oncol. 2011 Feb;5(1):36-47
pubmed: 21163714
Front Genet. 2018 Dec 12;9:641
pubmed: 30619466
Mol Cell Endocrinol. 2007 Mar 30;268(1-2):37-49
pubmed: 17316976
Nat Rev Drug Discov. 2020 Jun;19(6):389-413
pubmed: 32494050
J Cell Biochem. 2011 Dec;112(12):3786-96
pubmed: 21826705
Mol Endocrinol. 1997 Jun;11(6):747-54
pubmed: 9171238
Mol Cell Endocrinol. 2013 Aug 25;376(1-2):23-32
pubmed: 23748028
Mol Cancer Res. 2014 Nov;12(11):1644-1654
pubmed: 25030371
Breast Cancer Res Treat. 2010 Aug;123(1):51-8
pubmed: 19902352
Bioessays. 2022 Dec;44(12):e2200148
pubmed: 36192154
Breast Cancer Res Treat. 2019 Feb;174(1):121-127
pubmed: 30478785
Biomolecules. 2020 Mar 26;10(4):
pubmed: 32224970
Front Endocrinol (Lausanne). 2021 Mar 17;12:578250
pubmed: 33815268
Mol Cell Endocrinol. 2009 Sep 24;308(1-2):32-8
pubmed: 19464786
Cells. 2020 Feb 15;9(2):
pubmed: 32075246
Endocrinology. 2007 Jul;148(7):3236-45
pubmed: 17379646
Front Endocrinol (Lausanne). 2014 May 06;5:66
pubmed: 24834064
Amino Acids. 2017 Apr;49(4):705-713
pubmed: 28185014
Int J Endocrinol. 2022 May 9;2022:7690166
pubmed: 35586275
Int J Mol Sci. 2018 Dec 02;19(12):
pubmed: 30513833

Auteurs

Marilena Kampa (M)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Rosamaria Lappano (R)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Fedora Grande (F)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Bruno Rizzuti (B)

CNR-NANOTEC, SS Rende, Department of Physics, University of Calabria, 87036 Rende, Italy.
Institute of Biocomputation and Physics of Complex Systems, Joint Unit GBsC-CSIC-BIFI, University of Zaragoza, 50018 Zaragoza, Spain.

Marcello Maggiolini (M)

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Elias Castanas (E)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Yves Jacquot (Y)

CiTCoM, CNRS UMR 8038, INSERM U1268, Faculty of Pharmacy of Paris, University Paris Cité, CEDEX 06, 75270 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH